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Abstract
Background: Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) result in severe joint destruction and functional
disability if left untreated. We aim to develop tools that help patients with RA and PsA to understand and experience
the impact of inflammatory joint disease on the integrity of their (juxta-articular) bone and increase adherence to
medical treatment. In this study, we used high-resolution peripheral quantitative computed tomography (HR-pQCT) to
develop 3D prototypes of patients’ finger joints.
Methods: HR-pQCT (XtremeCT, Scanco) measurements were performed in healthy individuals and patients with
inflammatory joint disease, followed by a 3D print using the objet30 printer. Healthy participants (n = 10), and patients
(n = 15 with RA and 15 with PsA) underwent a detailed, standardized interview with demonstration of printed joints.
Results: Utilizing HR-pQCT images of metacarpophalangeal (MCP) heads, high quality and exact 3D prints as
prototypes were created. Erosions in different sizes and the trabecular network printed in detail were visualized,
demonstrating structural reduction in arthritic vs. healthy bone. After demonstration of 3D prints (healthy vs. erosive
joint, visual and haptic) 26/39 (66%) participants (including healthy volunteers) were deeply affected, often quoting
“shock”. Of the patients with RA and PsA, 13/15 (86%) and 11/15 (73%), respectively, stated that they would rethink
their attitude to medication adherence. More importantly, 21/24 patients with RA or PsA (87.5%) expressed that they
would have wished to see such 3D prints during their first disease-specific conversations.
Conclusion: Using arthro-haptic 3D printed prototypes of joints may help to better understand the impact of
inflammatory arthritides on bone integrity and long-term damage.
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Background
Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are
inflammatory diseases, which lead to joint destruction
and functional disability if not adequately treated [1–3].
In RA, autoantibodies such as rheumatoid factor or anti-
citrullinated peptide antibodies (ACPA) are typical
serologic findings and are strongly associated with erosive
disease [4]. Aside from bone erosion, pathognomonic
features of RA comprise articular and periarticular bone
loss and loss of trabeculation [5, 6]. In PsA no immune
factor has been described yet, and clinically joint-
associated bone changes include erosive disease and
juxta-articular bone remodeling [2, 7–10].
A panel of highly effective and approved immunosup-
pressive drugs is available to treat inflammation and to
avoid joint damage [3]. Despite these treatment opportun-
ities, recent studies demonstrated poor adherence to these
drugs [11, 12]. The reasons for this are multifactorial;
however, it is mainly influenced by medical beliefs and
lack of understanding of the disease [13]. Current tools for
patients comprise leaflets and brochures, digital tools such
as apps and website content and patient communities.
* Correspondence: axel.hueber@uk-erlangen.de
†Equal contributors
1Department of Internal Medicine 3 – Rheumatology and Immunology,
Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and
Universitätsklinikum Erlangen, Ulmenweg 18, 91054 Erlangen, Germany
2Department of Internal Medicine 3 and Institute for Clinical Immunology,
University of Erlangen-Nuremberg, Ulmenweg 18, 90154 Erlangen, Germany
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kleyer et al. Arthritis Research & Therapy  (2017) 19:34 
DOI 10.1186/s13075-017-1234-z
Most of these tools have either not been evaluated
scientifically or have not improved adherence when tested
in clinical trials [14].
Focusing on the damage induced by inflammatory arth-
ritis, radiographic techniques can be used to visualize
bone changes. To date, conventional radiographs of the
hands and feet are the gold standard in detecting and
monitoring erosions; however, this method captures im-
ages only two dimensions and only larger sized erosions
are depicted. High-resolution peripheral quantitative com-
puted tomography (HR-pQCT) is approved to determine
bone mineral density in human radial and tibial bone [15].
In recent years HR-pQCT has been shown to be a feasible
instrument to evaluate bone microstructure such as
erosions, osteophytes, articular trabecular network and
the cortical border of arthritic finger joints. In contrast to
conventional radiographs, HR-pQCT allows three-
dimensional visualization of the scanned bone and exact
separation of trabecular and cortical bone compartments,
at a resolution of 82 μm [6, 16–19]. Generation of
computed tomography (CT) images is complex, and not
easily usable for day-to-day patient contacts, because 3D
features are not available on every desktop computer.
Three-dimensional (3D) printing allows prototyping with
almost any material. It is a rapid emerging technology, easy
to use and quickly accessible. Different printing methods
are available, with main principles in common: the gener-
ation of a 3D printed prototype model on the basis of a
computer-aided design (CAD) model is transformed into a
standard triangulation language (STL) file and after transfer
to the 3D printer is printed by either polyjet, stereolithog-
raphy or other procedures [20]. Different materials such as
plastic or metal can be used. So far, medical approaches to
3D printing include planning for surgery, implant devices
and bioprinting of tissue structures [21–24].
In this experimental study, we tested (1) the feasibility
to generate exact 3D printed prototypes of arthritic and
healthy joints from cross-sectional HR-pQCT data and
in longitudinal HR-pQCT of a patient with RA, captured
in a video to explain the development of erosion, and (2)
whether patients accept such prototypes and if these
lead to improvement in understanding disease.
Methods
Patient characteristics and image selection
HR-pQCT (XtremeCT, Scanco) measurements were per-
formed as previously described in other studies [5, 6]. For
3D printing we selected images of healthy individuals and
patients with RA at different stages of disease ranging from
erosive, destructive disease to non-erosive bone alterations.
To explain the course of different types of bone erosions
we chose a female, ACPA-positive patient with RA, treated
with a biologic disease-modifying antirheumatic drug
(DMARD). To test the acceptance and understanding of
printed joints in interviews, 40 people were selected com-
prising 10 healthy participants, 15 patients with RA and 15
patients with PsA. All datasets were pseudonymized.
Three-dimensional printing of joints from HR-pQCT data
For 3D printing we chose the objet30 Printer from Stratasys
due to its extraordinary resolution at 24 μm. As the data
source for our concept models we chose HR-pQCT
(Xtreme CT, Scanco) images of the metacarpal heads. In
contrast to magnetic resonance imaging (MRI), HR-pQCT
acquires images at a much higher resolution and depicts
bone microstructure [19]. Furthermore, compared to
clinical CT the radiation dose is considerably lower. After
motion grade assessment using sixfold zoom of the head of
the metacarpophalangeal (MCP) joint the respective bone
area was contoured and segmented. The segmented bone
was used as the source for STL file creation with SCANCO
software. Files were exported and repaired with Netfabb
basic (Ver. 5.2.1) and Meshmixer (Ver. 10.8.126) and a final
3D printable file was generated and sent to the objet30
platform for 3D printing.
Movie production
For visualization of erosions and cystic structures that
develop during the course of disease one ACPA-positive
female patient (50 years of age) with RA was selected
with a dataset covering 2 years of disease duration. The
cystic erosive structure was artificially cut in a sagittal
section using Netfabb basic (Ver. 5.2.1) and Meshmixer
(Ver. 10.8.126) software. The video file was captured
using the Canon EOS 5D Mark 3 and Canon EOS 650D
and was modified using Adobe Premiere CC 2014.
Interview study design
To study the acceptance of 3D prints, 10 healthy partici-
pants (HP) (6 women and 4 men, average age 43.6 years),
15 patients with RA (11 women and 4 men, average age
56 years, average disease duration 14.3 years) and 15
patients with PsA (9 women and 6 men, average age
50 years, average disease duration 11.9 years, all of a
Caucasian ethnic background) were interviewed. Healthy
participants were informed about the diseases, using a
national society brochure about arthritis.
The interviews were held in German, were audio-recorded,
transcribed verbatim, translated into English and analyzed
(for the complete interview guideline see Additional file 1).
Interviews lasted about 10 to 20 minutes and were guided by
an interview schedule developed in collaboration with a
psychologist. Questions explored participants’ opinions of
therapy methods and their reactions to the demonstration of
a 3D printed prototype of an erosive MCP joint (Figs. 1
and 2). The joints were also demonstrated as pictures, to
allow a comparison. A detailed explanation of the joints
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was given to every participant afterwards. The coded
interview data were analyzed using NVivo10 software.
Results
From CT images to production of 3D printed prototypes
of finger joints
HR-pQCT images of a healthy intact second MCP (MCP2)
head and arthritic joints in ACPA-positive patients with RA
(n = 25) were used for prototype establishment. Following
file repair, a high-quality and exact 3D model was created
(Fig. 1, healthy joint).
For better visualization we chose an enlargement of 3:1
compared to the source data. Figure 2 displays representa-
tive printouts of MCP2 heads in three different angles
(dorsal/radial/trabecular) in three different patients with
pathognomonic bone alterations, for arthritic joints.
Different-sized erosions and the trabecular network were
visualized in detail, demonstrating a massive structural
reduction in arthritic vs. healthy bone. A distinct pattern
of localization was detected in erosions. The erosions were
mainly found at a region close beneath the radial/ulnar or
dorsal cartilage area (Fig. 2). No erosions were identified
at the palmar location.
Motional visualization of erosive disease
Examining changes in the progression of disease is pivotal
for understanding the pathogenesis of RA. Using longitu-
dinal follow-up scans of the MCP joints, we observed the
development of erosion in a representative patient. Artificial
truncation through a cystic structure that defined erosion
that was yet to develop separated the MCP head into two
parts. This was 3D-printed for demonstration (Fig. 3) and
filmed for motional visualization (Additional file 2). Inter-
estingly, the print depicted two types of erosion. A dorsal
porous structured cortical defect with irregularly shaped
borders depicted erosion that usually could not be detected
on conventional radiographs. In addition, a cystic structure
that was also detected by MRI showed contrast enhance-
ment (Fig. 3). At 2-year follow up the cystic structure con-
tained new erosion; however, the borders showed signs of
thickening. Thus, this video presented an illustration that
was close to reality, of an arthro-haptic experience with a
focus on joint architecture and bone changes over time.
Fig. 1 Three-dimensional (3D) model prototype of the second
metacarpophalangeal (MCP2) joint. Anatomical structure of MCP joints
is depicted (left panel). Lower right panel demonstrates high-resolution
peripheral quantitative computed tomography 3D reconstruction of a
healthy MCP2 joint. Upper right panel 3D high-resolution model printed
using a polyjet procedure (objet30, Stratasys)
Fig. 2 Three-dimensional (3D) visualization of rheumatoid arthritis pathological change. Three individual metacarpophalangeal (MCP) heads in
patients with rheumatoid arthritis are presented demonstrating erosive disease and osteophytes (left, middle, right panel). Further, loss of
trabecular structure (middle panel, bottom row) and increased porosity are visible in all examples (in comparison to Fig. 1). 3D models exactly
depict 3D high-resolution peripheral quantitative computed tomography reconstructions
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Perception of 3D printed prototypes
Following the establishment of 3D prototypes we next
sought to understand how implementation of 3D joints can
be utilized for patient communication. Qualitative inter-
views were performed in healthy participants who had been
informed about inflammatory joint disease. In this setting,
this small sample simulates newly diagnosed patients.
After 3D demonstration (healthy joint vs. erosive joint,
visual and haptic), healthy participants were asked for their
emotional opinion. Nine out of ten healthy participants
were deeply affected, often quoting “shock”. Although they
had been well-informed earlier, participants did not expect
such an impressive impact of the demonstration (Table 1,
quotes 1-5). Nevertheless, the demonstration was appreci-
ated by 8 out of 10 participants (Table 1, quotes 6-8). One
participant said that it might be too much of a shock and
that a series of 3D printed prototypes with more intermedi-
ate versions could be superior (Table 1, quote 9).
Questioned about the difference between a 3D model
and a computer animation, 9 out of 10 participants
stated that they preferred the 3D model. Also the haptic
demonstration was more concrete and seemed to emo-
tionally affect participants on a larger scale. The less fic-
tional 3D model could be advantageous, especially for
older patients (Table 1, quotes 10-12). When questioned
about their preference for either individual 3D joints or
a representative model, 6 out of 10 participants
expressed a preference for use of their own joints, while
2 participants were indifferent and 2 participants said
that an example would be sufficient.
M-any patients with arthritis (19/30 (63%)) reported
that they were shocked at the time of the first diagnosis
and that the disease severely influenced their lives (Table 1,
quotes 1-3). Being confronted with the 3D printed proto-
type, more than half of the patients were also deeply
affected (17/29 (58.6%)), whereas another 7/29 (24%)
valued the illustration demonstrated. Although most of
them had seen schematic pictures of joint disease before,
the direct comparison between the healthy and the erosive
model, and the haptic experience, had an emotional
impact on most of the patients (Table 1, quotes 4-8).
Following the feedback from healthy participants on the
advantages of a 3D model series (addition of an intermedi-
ate erosive disease model to the healthy and very erosive
disease model), 11/11 patients with RA and 9/12 (75%)
patients with PsA believed that a series of three models
would have better effects (Table 1, quotes 9-10).
Comparing the difference between a 3D model and a
computer animation, participants clearly preferred the 3D
model (12/15 (80%) of the patients with RA and 10/15
(66%) of the patients with PsA) (Table 1, quotes 11-14).
The possibility of touching the models, feeling the erosions
and being able to turn it, was very important for internal-
ization according to 22/30 (73%) patients (quotes 13, 14):
8/15 (53.3%) of the patients with RA and 8/12 (66.6%) of
the patients with PsA indicated they would appreciate see-
ing their own joint as a 3D model. Some emphasized that it
might increase adherence, as patients are personally con-
fronted (Table 1, quote 15). Of the patients with RA, 13/15
(86%) and 11/15 (73%) of the patients with PsA stated that
they would rethink their attitude to medication adherence
after being confronted with the 3D printed prototypes
(Table 1, quotes 16-18). More importantly, 21/24 (87.5%) of
patients with RA or PsA said that they would have wished
to see such 3D prints during their first disease-specific con-
versations. Thus, these interviews endorse the use of 3D
prints for patient information and could have an impact on
medication adherence.
Discussion
In this study, we introduced 3D printing in the context of
rheumatology and inflammatory arthritis. First, we demon-
strated the feasibility of bone prototyping using the combin-
ation of HR-pQCT and a desktop 3D printer. We created
individual joint models with an extremely high resolution,
which depict the trabecular network and erosive changes.
Second, we demonstrated erosive change and development
of erosions over time. Last, we tested patients’ reactions and
their views on future use of 3D prints in patient-doctor
communication.
In the current study a poly-jet modeling procedure was
used. Also stereolithographic 3D printers achieve high-
resolution 3D prints in the range of microns (a set of 10 in-
dividual joints were printed as proof of concept, data not
Fig. 3 Preparation of a truncated 3D metacarpophalangeal (MCP)
head for video presentation. Magnetic resonance imaging (MRI) shows
the cystic structure in the third MCP head in a patient with rheumatoid
arthritis (left panel, red circle). In a 3D reconstruction this structure was
artificially cut to demonstrate the internal bone formation (right upper
panel). 3D prints of both halves resemble the cystic structure seen on
MRI and computed tomography. Bottom right panel: Left red arrow
shows the MRI corresponded cystic structure; right arrow connection
tothe trabecular network. Video motion (Additional file 2) illustrates
arthro-haptic experience for patient demonstration
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Theme 1: How does it make you feel to see this?
1 005 “Seeing the degeneration is frightening.”
2 006 “It shocks. I’d do anything to prevent
it from worsening.”
3 005 “It would not scare me off, it would
rather wake me up.”
4 009 “It’s terrible. It clearly shows that the
process is irreversible.”
5 005 “Wow, that’s shocking- in some areas
there is nothing left of the bone.”
Theme 2: What do you think about the demonstration of the healthy
and the erosive joint?
6 005 “To see it from the inside […] to
realize what it looks like under my
skin- it’s on the one hand macabre,
but […] it would affect me more and
therefore I would not forget my
medication. Because I have now seen
what could happen to my joints if I
don’t do anything about it.”
7 006 “You know, sometimes it’s difficult for us
as ordinary people to understand what
the doctor is trying to tell you. But with
this model-it’s the same thing with a car
crash: when I see where the damage is,
I can come up with something to fix it. I
know what to do, how to repair it. Hav-
ing seen this damage (because of RA
and PsA) and the doctor telling me
what to do about it- it’s just obvious
and not anonymous anymore.”
8 013 “The diagnosis scares anyway, so I guess
it’s better to know what you’re dealing
with and what might happen. Being left
in the dark is even scarier. And since
you can’t change anything about it
anymore, you have to cope with it, if
you want to stop it from proceeding.
So yes, I would prefer being informed
with such a 3D model.”
9 012 “[…] 3 models is a reasonable option,
because it shows, that one hasn’t
reached the final stage yet, and that
one can still do something about it.”
Theme 3: What would be the difference between a computer animation
or a 3D model?
10 006 “It’s (the 3Dmodel) more real, not as abstract.”
11 012 “I think that some people don’t take
their medication, because they don’t
understand it, they don’t have a
relation to it and I am sure, that this
3D model could somehow reach
patients easier than the more
distanced computer animation.”
12 011 “I believe that especially older patients,
who don’t deal with computers that
often, might prefer the 3D model.”











Theme 1: What did the diagnosis mean for you?
1 2.0 “It was a shock. Embarrassing, that
everybody could see the dandruff. I
didn’t wear black any longer.”
2 1.1.4 “I try to put my better hand above the
distorted fingers on pictures so that
not everybody will see it immediately.”
3 2.5 “You’re going to laugh, but I was relieved
that I finally knew what was going on
and a spade was a spade. I was moving
like an old man and was simply glad to
have found somebody who told me
what was happening to me.”
Theme 2: “What do you feel like, being confronted with the 3D print model?”
4 2.1 “There is always this fear. If I take a
look at the degenerated one, I just
think-great, if I don’t watch out, mine
will look exactly as degenerated.”
5 2.2 “I’ve got to be serious. I didn’t think it
was that bad.”
6 2.6 “I’m just glad that my joints haven’t
degenerated as far.”
7 3.3 “I think it might be especially helpful
for patients who have just been
diagnosed or who would not deal
with it reasonably.”
8 2.0 “The 3D model is simply very close. I
appreciate that. Seeing this affects,
because I know that it could be me
and that it might get worse one day.”
Theme 3: “Would you prefer a series of 3 models, instead of 2, so that
the process could be demonstrated in a more precise way?”
9 2.5 “I think this would be great, especially
for rather sensitive people, who can
be sloppy as well and who could
benefit from the demonstration.”
10 1.1.1 “That would be great, because it
could wake up, but wouldn’t shock
too much all the same.”
Theme 4: “What would be the difference between a computer
animation and the 3D print model?
11 2.4 “It is always better to hold something
than to see it on pictures only.
Especially for older people who don’t
deal with computers that often.”
12 2.5 “A 3D model is closer […] and the
impression lasts longer. We live in a
society that deals a lot with computers
and I think we have learnt how to turn
out things we don’t want to look at. The
print is more impressive, more gripping.”
13 2.9 “Reality is always better.”
14 1.4 “It’s just a different feeling, I can hold
it and feel it.”
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shown). The printing material allowed the creation of very
durable samples. Printing took 4 to 8 hours depending on
the size of the prototype, the resolution and the type of
printer. Although 3D STL file creation of joints was simple
due its implementation in the HR-pQCT software, moder-
ate effort was necessary to repair and correct the file for
error-free printing. Modern platforms already provide STL
files for various objects (e.g. thingiverse.com). Also bones
such as the tibia or full hands are available on such systems.
However, lack of resolution and pathologic changes negate
the utility of the files offered for demonstration.
Theoretically and in practice, other imaging 3D files
could also be printed, such as in MRI or 3D ultrasound.
Disadvantages are limited resolution (MRI) and lack of
intra-osseous structure (ultrasound). Although the tech-
nical setup already exists, the realization demands a cer-
tain program user skill [25]. We predict that in due course
future technical compound and software connections will
be able to print different medical 3D imaging files by
plug-and-play setups [20]. As a prototype example, we
were able to visualize different types of erosions, which
cannot be seen on conventional radiographs due to the
anatomical distribution and small size. Demonstrating the
formation of erosion from an MRI contrast-enhanced cys-
tic structure depicts the power of this approach to exactly
localize and quantify newly occurring structural damage
in patients with arthritis.
In the patient interviews, the limitation of this study
was the lack of comparison of 3D prints with 3D images
or computer animations. Although we asked about par-
ticipants preferences, we did not show the alternatives.
Furthermore, we did not include a comparator in this
study.
Focusing on feasibility, individualized 3D prints demand
the image of the individual patient. HR-pQCT imaging is
nearly as cost-intensive as common CT imaging. With the
further file correction and print processing this process
exceeds the simple presentation of conventional radiog-
raphy and/or ultrasound.
Another drawback for individualized prints is the
limited access to HR-pQCT. However, using showcase 3D
prints can provide a cheap solution (approximately 1–10
€) demonstrating different stages of diseases on represen-
tative joint constructs. In this study a qualitative approach
was chosen to gather crucial points from the patient’s per-
spective. This limitation of lack of quantifiable data needs
to be addressed in further studies. Despite the abstract
visualization of enlarged MCP joints, patients recognized
the prototypes as bone models and appreciated the added
value for future patient-doctor communication. We expe-
rienced frequent requests for our 3D models to be used in
daily practice after demonstration to rheumatologists.
Conclusions
This manuscript provides a new approach utilizing 3D
printing techniques to demonstrate joint disease. More-
over, we were able to prototype reconstructions of early
to late-stage destruction of the finger joints. In sum-
mary, using individual arthro-haptic joint constructs will
address a gap in patient education and disease under-
standing. In the future, we will set up a platform for
downloadable 3D joints for home/office-based printing.
Additional files
Additional file 1: Interview guideline. (DOCX 18 kb)
Additional file 2: Video capture of an artificially truncated MCP head.
This video illustrates the making and development of 3D prototypes.
Focusing on an artificial cut of the metacarpal phalangeal head, a cystic
structure inside the bone, and the bone surface, are demonstrated at two
time points. At first the cyst is encapsulated, with no connection to the
joint space and dorsal irregular erosion is visualized; over time (2 years)
new erosion develops from the cystic structure, with a distinguished
pattern compared to the dorsal one. The video also demonstrates the
visual experience of 3D prototypes (MPG 26136 kb)
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Table 1 Selection of representative interview quotes
(Continued)
Theme 5: “Would you prefer being confronted with an example joint or
your own joint as a 3D print model?”
15 2.3 “Seeing my own would motivate me
even more. Because I have just seen
my very own joint and that is worse
than seeing someone else’s.”
Theme 6: “Could this demonstration increase patients’ adherence?”
16 1.1.6 “I definitely think that [it would be
adherence supportive], yes. If I
wouldn’t already take my medicine, I
would by now.”
17 1.1.2 “Well, I think if you’d show this to
someone, who doesn’t know much
about medicine, you could […] make
him understand and take the
medication to avoid the degeneration.”
18 2.6 “Especially if the patient thinks, that
the pills are only against the pain and
if he doesn’t realize what else is
going to happen […], that there is a
real, degenerative change in his body
and the process is irreversible.”
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